CN113520954A - 一种中药祛痘膏及其生产工艺 - Google Patents
一种中药祛痘膏及其生产工艺 Download PDFInfo
- Publication number
- CN113520954A CN113520954A CN202110984838.9A CN202110984838A CN113520954A CN 113520954 A CN113520954 A CN 113520954A CN 202110984838 A CN202110984838 A CN 202110984838A CN 113520954 A CN113520954 A CN 113520954A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- chinese medicine
- parts
- essential oil
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 69
- 206010000496 acne Diseases 0.000 title claims abstract description 69
- 239000003814 drug Substances 0.000 title claims abstract description 64
- 239000006071 cream Substances 0.000 title claims abstract description 57
- 238000004519 manufacturing process Methods 0.000 title abstract description 9
- 239000000341 volatile oil Substances 0.000 claims abstract description 40
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000004094 surface-active agent Substances 0.000 claims abstract description 11
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 240000003553 Leptospermum scoparium Species 0.000 claims abstract description 10
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 10
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 10
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 10
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 9
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 9
- 239000000049 pigment Substances 0.000 claims abstract description 9
- 239000008367 deionised water Substances 0.000 claims abstract description 8
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 8
- 239000004166 Lanolin Substances 0.000 claims abstract description 7
- 235000021355 Stearic acid Nutrition 0.000 claims abstract description 7
- 229940039717 lanolin Drugs 0.000 claims abstract description 7
- 235000019388 lanolin Nutrition 0.000 claims abstract description 7
- 239000002480 mineral oil Substances 0.000 claims abstract description 7
- 235000010446 mineral oil Nutrition 0.000 claims abstract description 7
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 7
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims abstract description 7
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000002674 ointment Substances 0.000 claims abstract description 7
- 239000008117 stearic acid Substances 0.000 claims abstract description 7
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract description 6
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 6
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims abstract description 6
- 239000003883 ointment base Substances 0.000 claims abstract description 6
- 229940064064 purslane extract Drugs 0.000 claims abstract description 6
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 5
- 229940082500 cetostearyl alcohol Drugs 0.000 claims abstract description 5
- 229940075529 glyceryl stearate Drugs 0.000 claims abstract description 5
- 239000003755 preservative agent Substances 0.000 claims abstract description 5
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims abstract description 5
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000003880 Calendula Nutrition 0.000 claims abstract description 4
- 240000001432 Calendula officinalis Species 0.000 claims abstract description 4
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 4
- 239000004006 olive oil Substances 0.000 claims abstract description 4
- 235000008390 olive oil Nutrition 0.000 claims abstract description 4
- 239000003205 fragrance Substances 0.000 claims abstract description 3
- 238000002156 mixing Methods 0.000 claims description 34
- 238000002360 preparation method Methods 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 21
- 238000000605 extraction Methods 0.000 claims description 14
- 241000628997 Flos Species 0.000 claims description 12
- 239000003921 oil Substances 0.000 claims description 11
- 235000019198 oils Nutrition 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical group [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 8
- 229940009868 aluminum magnesium silicate Drugs 0.000 claims description 8
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 claims description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 7
- 235000013599 spices Nutrition 0.000 claims description 6
- 230000002421 anti-septic effect Effects 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 238000011049 filling Methods 0.000 claims description 5
- 230000009969 flowable effect Effects 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 230000001815 facial effect Effects 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 239000000787 lecithin Substances 0.000 claims description 3
- 235000010445 lecithin Nutrition 0.000 claims description 3
- 229940067606 lecithin Drugs 0.000 claims description 3
- 230000002829 reductive effect Effects 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 2
- 229960003237 betaine Drugs 0.000 claims description 2
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 18
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 229960002227 clindamycin Drugs 0.000 abstract description 4
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 10
- 229940126680 traditional chinese medicines Drugs 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 4
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical group O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 4
- 208000020154 Acnes Diseases 0.000 description 3
- 241000186427 Cutibacterium acnes Species 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229940055019 propionibacterium acne Drugs 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 241000565319 Butea monosperma Species 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000208682 Liquidambar Species 0.000 description 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 description 1
- 241001571736 Lysimachia foenum-graecum Species 0.000 description 1
- 235000003805 Musa ABB Group Nutrition 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 244000265736 Nelumbo pentapetala Species 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010054107 Nodule Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 235000015266 Plantago major Nutrition 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种中药祛痘膏的配方及其生产工艺和应用,所述中药祛痘膏,由中药有效成分和药膏基础组分组成,所述中药有效成分包括马齿苋提取物、生大黄粉、菊花精油、金银花精油、金盏花精油、茶树精油、橄榄油;所述药膏基础组分包括甘油硬脂酸酯、矿物油/羊毛脂醇、鲸蜡硬脂醇、硬脂酸、去离子水、丙二醇、羧甲基纤维素、镁铝硅酸盐、三乙醇胺、二氧化钛、颜料、表面活性剂、香料和防腐剂。本发明公开的中药祛痘膏选择地道药材和低温加工,最大可能保留中药有效成分,与西药膏剂基础组分相结合,形成优于西药克林霉素疗效的配方,并且疗效稳定。
Description
技术领域
本发明涉及一种护肤用品,具体涉及一种中药祛痘膏及其生产工艺以及应用。
背景技术
痤疮也称为青春痘,面部痤疮就是脸上长青春痘,这是一种常见的皮肤病,一般多见于青少年。常见症状有炎性丘疹,脓疱,结节等。痤疮是常见的皮肤病之一,有关的流行病学分析显示44.5%的青少年患有痤疮。痤疮常常发生在面部,若不治疗,容易遗留色素沉着或瘢痕,影响病人的容貌。
痘痘的成因是非常复杂的,市面上的祛痘产品不仅仅是通过抑制达到祛痘效果,更是有通过催熟的方式加快痘痘的生长,或者通过祛痘膏的杀菌消炎功效可以帮助痘痘褪红。
常见的祛痘膏蕴含的成分多以酸性和消炎型的成分为主。酸性物质能分解痘痘中的油脂,而消炎型成分则会抑制痘痘生长。比如水杨酸、尿囊素、茶树油等。
治疗痤疮常应用含有激素药物、甲硝唑、抗生素、维A酸、过氧化苯甲酰成分的祛痘产品,但易引发多种不良反应,并且耐药易复发。近年来出现的壳聚糖护创凝胶、芦荟凝胶等祛痘膏,添加了具有祛痘功效的中药提取物成分,治疗痤疮疗效好、毒副作用小,但有效成分吸收不稳定,疗效难以保障。
但是,中药祛痘膏产品采用中药传统方法,煎煮浓缩为膏,没有发挥出中药的独特优势。比如:蒲公英2-4份,高丽参2-4份,车前草2-4份,紫丁花1-2 份,连翘1-2份,金银花1-2份。该方采用煎煮浓缩的传统中药膏剂方法制成,疗效缓慢,膏剂不易储存。
比如CN104940361A一种祛痘膏及其制备方法,该祛痘膏由活性成分和辅料制成,所述的活性成分由如下重量份的中药材原料经水提醇沉制备而得:黄莲花 20-32份、灵香草20-32份、芜菁子12-18份、佛手15-25份、路路通10-18份。该祛痘膏有显著的抑制座疮丙酸杆菌的功效,可抑制座疮的产生。但是,水提醇沉法有效成分收率较低。另外该膏剂稳定性较差,有效期较短,与其基础配方有直接关系。
发明内容
针对上述问题,本发明公开了一种中药祛痘膏及其生产工艺,吸收传统中药整体调理的思路,以西药膏剂基础配方与传统中药有效成分相结合,避免西药耐药性和中药靶点宽泛的缺点,扬长避短,在制剂工艺上避免中西药相互作用。
本发明包括以下技术方案:
一种中药祛痘膏,由中药有效成分和药膏基础组分组成,所述中药有效成分包括马齿苋提取物、生大黄粉、菊花精油、金银花精油、金盏花精油、茶树精油、橄榄油;所述药膏基础组分包括甘油硬脂酸酯、矿物油/羊毛脂醇、鲸蜡硬脂醇、硬脂酸、去离子水、丙二醇、羧甲基纤维素、铝镁硅酸盐、三乙醇胺、二氧化钛、颜料、表面活性剂、香料和防腐剂。
进一步的,上述一种中药祛痘膏,所述中药有效成分的按质量份数由以下成分组成:
进一步的,上述一种中药祛痘膏,所述药膏基础组分按质量分数由以下成分组成:
进一步的,上述一种中药祛痘膏,所述颜料为氧化铁。
进一步的,上述一种中药祛痘膏,所述表面活性剂选自卵磷脂类,氨基酸型或甜菜碱型中的一种或者多种。
进一步的,上述一种中药祛痘膏,所述表面活性剂为氢化卵磷脂。
进一步的,上述一种中药祛痘膏,所述马齿苋提取物采用超临界CO2流体萃取装置提取:将清洗粉碎后的马齿苋在萃取装置中循环萃取,调节CO2流量,萃取过程温度小于60℃,压强维持40Mpa,保持恒温恒压萃取2小时以上。
进一步的,上述一种中药祛痘膏的制备工艺,包括以下步骤:
S1将马齿苋提取物与生大黄粉混合,混合破碎为20-100μm颗粒,取出置于配料罐,依次加入茶树精油菊花精油、金银花精油、金盏花精油,在配料罐中 500-1500r/min搅拌30分钟,再加入适量橄榄油搅拌10min制成能流动的膏状物A备用,上述制备过程中温度不超过40℃;
S2将羧甲基纤维素在混合器分散于丙二醇和三乙醇胺中,加入60-65℃去离子水搅拌30min,再加入铝镁硅酸盐搅拌至完全混合均匀为止,制成水相;将甘油硬脂酸酯、矿物油/羊毛脂醇、鲸蜡硬脂醇、硬脂酸混合,且加热至60-65℃,制成油相;在500~1000r/min下,在混合器中将水相加入到油相,且不断搅拌,加入颜料搅拌冷却,降温至30℃时加入表面活性剂;随后在均质机中进行均质,制成膏状混合物B;
S3按照A:B为1:1-1:4的比例进行混合,再加入香料、防腐剂和二氧化钛等颜料;在均质机内混合30分钟,包装充填,制成祛痘膏成品。
进一步的,上述一种中药祛痘膏在制备预防或者治疗面部痘痘的化妆品或药品中的的用途。
本发明具有以下有益效果:
1本发明中的中药有效成分具有中药耐药性小、无激素的优点,比常见西药祛痘膏更加温和,治疗后复发率低等优点。
2本发明采用超临界CO2萃取装置低温萃取中药有效成分,比常见中药祛痘膏疗效稳定,各项生产指标确切、质量易控。
3本发明公开了一种中西药配方联合治疗痤疮的方法和应用。
附图说明
附图1为本发明中一种中药祛痘膏的制备工艺的总体流程图;
附图2为本发明实施例4中的抗菌活性测试图。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。本发明中所述的适量,为本领域内普通技术人员根据国家技术规范和生产实际情况所决定的用量。本发明中所述的原料如无特殊说明,均为商业购得。
(一)中药原料及来源
1.马齿苋提取物(低温):采用超临界CO2流体萃取装置,将清洗粉碎后的马齿苋,在萃取装置中循环萃取,调节CO2流量,萃取过程温度小于60℃,压强维持40Mpa,保持恒温恒压萃取2小时以上。比一般醇提和水提效果要好。也可采购市场上符合上述条件的马齿苋提取物-西安百川生物科技有限公司。
2.生大黄粉:破碎生大黄(产地甘肃),100%过80目筛;
3.菊花精油:山东泰安市嘉叶生物科技有限公司
4.金银花精油:江西雪松天然药用油有限公司
5.金盏花精油:江西景旺天然香料有限公司
6.茶树精油:江苏润丰合成科技有限公司
7.橄榄油:甘肃武都田丰油橄榄苗木基地
(二)其他原料及来源(均为医药级或者食品级)
1.甘油硬脂酸酯:浙江物美生物科技有限公司
2.矿物油/羊毛脂醇:苏州新亿生物科技有限公司
3.鲸蜡硬脂醇:上海倍特化工有限公司
4.硬脂酸:上海倍特化工有限公司
5.去离子水:自制
6.丙二醇:陶氏化学(上海)有限公司
7.羧甲基纤维素:常州市国宇环保科技有限公司
8.铝镁硅酸盐:斯百全化学(上海)有限公司
9.三乙醇胺(99%):陶氏化学(上海)有限公司
10.二氧化钛:上海缘江化工有限公司
11.氧化铁:颜料,可以不用。西安天正药用辅料有限公司
12.活性剂:卵磷脂类表面活性剂:河北百味生物科技有限公司
13.香料,防腐剂:苯甲酸钠等,可以不用。山西锦洋药用辅料有限公司
实施例1
中药祛痘膏制备工艺1
表1 实施例1中药有效成分配方表
(一)有效成分制备方法:
按照表1将马齿苋提取物与生大黄粉混合,在气流机中破碎为20-100μm 颗粒,取出置于配料罐,依次加入茶树精油菊花精油、金银花精油、金盏花精油,在配料罐中50-100r/min搅拌30分钟,再加入适量橄榄油搅拌10min制成能流动的膏状物A备用,注意在制备过程中温度不超过40℃。
备注:气流机:FQ02气流粉碎机-山东丰力重工有限公司
配料罐:IC-100配料罐-北京博医康实验仪器有限公司
表2 实施例2药膏基础组分(纯度达到医药级)
(二)基础组分制备方法:
1.按照表2配方将CMC在混合器A分散于丙二醇和三乙醇胺中,加入去离子水(60-65℃)搅拌30min,再加入veegum搅拌至完全混合均匀为止,制成水相。
2.将1、2、3、4混合,且加热至60-65℃,制成油相。
3.在500-1000r/min下,在混合器B中将水相加入到油相,充分混合。
4.加入氧化铁搅拌冷却,在30℃加入氢化卵磷脂类。
6.在均质机中进行均质,制成混合物B。
(三)混合制备祛痘膏
1.按照A:B为1:1的比例进行混合,再加入香料、防腐剂和二氧化钛等颜料。
2.在均质机内均质30分钟。
3.包装充填。
备注:
混合器A:TJ-Btype双联平行生物反应器-迪必尔生物工程(上海)有限公司
混合器B:SK-7.5/15静态混合器-启东市精博化工设备厂
均质机:JMS-180胶体磨-廊坊市通益机械有限公司
总体制备流程见图1。
实施例2
祛痘膏制备工艺2
表3 实施例2中药有效成分配方表
(一)有效成分制备方法:
按照表3将马齿苋提取物与生大黄粉混合,在气流机中破碎为20-100μm 颗粒,取出置于配料罐,依次加入茶树精油菊花精油、金银花精油、金盏花精油,在配料罐中50-100r/min搅拌30分钟,再加入适量橄榄油搅拌10min制成能流动的膏状物A备用,注意在制备过程中温度不超过40℃。
备注:气流机:FQ02气流粉碎机-山东丰力重工有限公司
配料罐:FY30配料罐-温州天兴机械有限公司
表4 实施例2药膏基础组分配方表(纯度达到医药级)
(二)基础组分制备方法:
1.按照表4配方将CMC在混合器A分散于丙二醇和三乙醇胺中,加入温水(60-65℃)搅拌30min,再加入铝镁硅酸盐搅拌至完全混合均匀为止,制成水相。
2.将1、2、3、4混合,且加热至60-65℃,制成油相。
3.在500-1000r/min下,在混合器B中将水相加入到油相,充分混合。
4.加入氧化铁搅拌冷却,在30℃加入氢化卵磷脂类。
6.在均质机中进行均质,制成混合物B。
(三)混合制备祛痘膏
1.按照A:B为3:7的比例进行混合,再加入香料、防腐剂和二氧化钛等颜料。
2.在均质机内均质30分钟。
3.包装充填。
备注:
混合器A:TJ-Btype双联平行生物反应器-迪必尔生物工程(上海)有限公司
混合器B:SK-7.5/15静态混合器-启东市精博化工设备厂
均质机:JMS-180胶体磨-廊坊市通益机械有限公司。
实施例3
祛痘膏制备工艺3
表5 实施例3中药有效成分配方表
(一)有效成分制备方法:
按照表5将马齿苋提取物与生大黄粉混合,在气流机中破碎为20-100μm 颗粒,取出置于配料罐,依次加入茶树精油菊花精油、金银花精油、金盏花精油,在配料罐中50-100r/min搅拌30分钟,再加入适量橄榄油搅拌10min制成能流动的膏状物A备用,注意在制备过程中温度不超过40℃。
备注:气流机:FQ02气流粉碎机-山东丰力重工有限公司
配料罐:FY30配料罐-温州天兴机械有限公司
表6 实施例3药膏基础组分配方表(纯度达到医药级)
(二)基础组分制备方法:
1.按照表6配方将CMC在混合器A分散于丙二醇和三乙醇胺中,加入温水 (60-65℃)搅拌30min,再加入铝镁硅酸盐搅拌至完全混合均匀为止,制成水相。
2.将1、2、3、4混合,且加热至60-65℃,制成油相。
3.在500-1000r/min下,在混合器B中将水相加入到油相,充分混合。
4.加入氧化铁搅拌冷却,在30℃加入药用氨基酸。
6.在均质机中进行均质,制成混合物B。
(三)混合制备祛痘膏
1.按照A:B为2:8的比例进行混合,再加入香料、防腐剂和二氧化钛等颜料。
2.在均质机内均质30分钟。
3.包装充填。
备注:
混合器A:TJ-Btype双联平行生物反应器-迪必尔生物工程(上海)有限公司
混合器B:SK-7.5/15静态混合器-启东市精博化工设备厂
均质机:JMS-180胶体磨-廊坊市通益机械有限公司。
实施例4
祛痘膏抗菌活性测试研究
经抗菌测试,本祛痘膏具有明显的抑制痤疮丙酸杆菌的功效,可以抑制痤疮的产生,对痤疮丙酸杆菌的最低抑菌质量浓度为0.3-0.4mg/mL,优于克林霉素乳膏的最低抑菌浓度,见图2。
实施例5
祛痘膏的临床应用研究
面部痤疮患者64例,男性27例,女性37例;年龄最小13岁,最大42岁;病程最短20d,最长10年。随机分为观察组和对照组。观察组32例,男性15 例,女性17例;年龄最小14岁,最大42岁;病程最短20d,最长10年,使用实施例2处方工艺制备的祛疻膏治疗。对照组32例,男性12例,女性20 例;年龄最小13岁,最大41岁;病程最短25d,最长9年,使用0.8%克林霉素乳膏治疗。两组病例在性别、年龄、病程等方面经统计学处理无显著差异,P>0.05,具有可比性。
使用方法:用清水清洗面部,取适量药膏,均匀涂抹于患处,每日2-3次,连续使用2周以上。
疗效标准:经2周治疗,皮损消退70%以上为显效;皮损消退30%以上为有效;皮损消退30%以下为无效。总有效率=(显效例数+有效例数)/总例数×100%。
治疗结果:如表7所示,观察组32例中显效13例,有效16例,无效3例,总有效率90.6%。对照组32例中显效10例,有效18例,无效4例,总有效率84.3%,汇总在表4-3中。复诊时观察组复发为0,对照组5例复发。显然,本发明的中药祛疻膏治疗痤疮效果略优于克林霉素乳膏。
表7 治疗有效率表
以上实施例1-5可知,本发明公开了一种中药祛痘膏及其生产工艺,吸收传统中药整体调理的思路,以西药膏剂基础配方与传统中药有效成分相结合,避免西药耐药性和中药靶点宽泛的缺点,扬长避短,在制剂工艺上避免中西药相互作用。
以上仅为本发明的较佳实施例而已,不能以此限定本发明的保护范围,即大凡依本发明权利要求书及发明内容所做的简单的等效变化与修改,皆仍属于本发明专利申请的保护范围。
Claims (9)
1.一种中药祛痘膏,其特征在于,由中药有效成分和药膏基础组分组成,所述中药有效成分包括马齿苋提取物、生大黄粉、菊花精油、金银花精油、金盏花精油、茶树精油、橄榄油;所述药膏基础组分包括甘油硬脂酸酯、矿物油/羊毛脂醇、鲸蜡硬脂醇、硬脂酸、去离子水、丙二醇、羧甲基纤维素、铝镁硅酸盐、三乙醇胺、二氧化钛、颜料、表面活性剂、香料和防腐剂。
2.根据权利要求1所述的一种中药祛痘膏,其特征在于,所述中药有效成分的按质量份数由以下成分组成:
马齿苋提取物 1-2份
生大黄粉 2-4份
菊花精油 1-3份
金银花精油 1-3份
金盏花精油 1-3份
茶树精油 1-2份
橄榄油 适量。
3.根据权利要求1所述的一种中药祛痘膏,其特征在于,所述药膏基础组分按质量分数由以下成分组成:
甘油硬脂酸酯 20-40份
矿物油/羊毛脂醇 30-60份
鲸蜡硬脂醇 5-20份
硬脂酸 10-30份
去离子水 适量
丙二醇 20-40份
羧甲基纤维素 1-3份
铝镁硅酸盐 1-20份
三乙醇胺 2-20份
二氧化钛 80-150份
颜料 适量
表面活性剂 30-80份
香料和防腐剂 适量。
4.根据权利要求1所述的一种中药祛痘膏,其特征在于,所述颜料为氧化铁。
5.根据权利要求1所述的一种中药祛痘膏,其特征在于,所述表面活性剂选自卵磷脂类,氨基酸型或甜菜碱型中的一种或者多种。
6.根据权利要求1所述的一种中药祛痘膏,其特征在于,所述表面活性剂为氢化卵磷脂。
7.根据权利要求1所述的一种中药祛痘膏,其特征在于,所述马齿苋提取物采用超临界CO2流体萃取装置提取:将清洗粉碎后的马齿苋在萃取装置中循环萃取,调节CO2流量,萃取过程温度小于60℃,压强维持40Mpa,保持恒温恒压萃取2小时以上。
8.如权利要求1-7任一项所述的中药祛痘膏的制备工艺,其特征在于,包括以下步骤:
S1将马齿苋提取物与生大黄粉混合,混合破碎为20-100μm颗粒,取出置于配料罐,依次加入茶树精油菊花精油、金银花精油、金盏花精油,在配料罐中500-1500r/min搅拌30分钟,再加入适量橄榄油搅拌10min制成能流动的膏状物A备用,上述制备过程中温度不超过40℃;
S2将羧甲基纤维素在混合器分散于丙二醇和三乙醇胺中,加入60-65℃去离子水搅拌30min,再加入铝镁硅酸盐搅拌至完全混合均匀为止,制成水相; 将甘油硬脂酸酯、矿物油/羊毛脂醇、鲸蜡硬脂醇、硬脂酸混合,且加热至60-65℃,制成油相;在500~1000r/min下,在混合器中将水相加入到油相,且不断搅拌,加入颜料搅拌冷却,降温至30℃时加入表面活性剂;随后在均质机中进行均质,制成膏状混合物B;
S3按照A:B为1:1-1:4的比例进行混合,再加入香料、防腐剂和二氧化钛等颜料;在均质机内混合30分钟,包装充填,制成祛痘膏成品。
9.如权利要求1-7任一项所述的中药祛痘膏在制备预防或者治疗面部痘痘的化妆品或药品中的的用途。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110984838.9A CN113520954A (zh) | 2021-08-24 | 2021-08-24 | 一种中药祛痘膏及其生产工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110984838.9A CN113520954A (zh) | 2021-08-24 | 2021-08-24 | 一种中药祛痘膏及其生产工艺 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113520954A true CN113520954A (zh) | 2021-10-22 |
Family
ID=78092905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110984838.9A Pending CN113520954A (zh) | 2021-08-24 | 2021-08-24 | 一种中药祛痘膏及其生产工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113520954A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102219669A (zh) * | 2010-04-13 | 2011-10-19 | 徐德钦 | 一种采用超临界co2流体萃取马齿苋亚麻酸的方法 |
CN103169641A (zh) * | 2013-03-14 | 2013-06-26 | 金红叶纸业集团有限公司 | 祛痘淡印组合物及应用其的纸巾 |
CN103463212A (zh) * | 2013-09-27 | 2013-12-25 | 罗成 | 一种中药祛痘、除印面膜及其制备方法 |
CN104940361A (zh) * | 2015-06-04 | 2015-09-30 | 青岛大学附属医院 | 一种祛痘膏及其制备方法 |
CN107929227A (zh) * | 2017-12-15 | 2018-04-20 | 柳州市汉象教育咨询有限责任公司 | 一种祛痘除印的药膏及其制备方法 |
-
2021
- 2021-08-24 CN CN202110984838.9A patent/CN113520954A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102219669A (zh) * | 2010-04-13 | 2011-10-19 | 徐德钦 | 一种采用超临界co2流体萃取马齿苋亚麻酸的方法 |
CN103169641A (zh) * | 2013-03-14 | 2013-06-26 | 金红叶纸业集团有限公司 | 祛痘淡印组合物及应用其的纸巾 |
CN103463212A (zh) * | 2013-09-27 | 2013-12-25 | 罗成 | 一种中药祛痘、除印面膜及其制备方法 |
CN104940361A (zh) * | 2015-06-04 | 2015-09-30 | 青岛大学附属医院 | 一种祛痘膏及其制备方法 |
CN107929227A (zh) * | 2017-12-15 | 2018-04-20 | 柳州市汉象教育咨询有限责任公司 | 一种祛痘除印的药膏及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6530817B2 (ja) | ニキビ除去スキンケア製品とその製造方法 | |
TWI432206B (zh) | 含有天然萃取物之組合的口腔用組成物及其用途 | |
KR100879032B1 (ko) | 천연 항균 및 항염 효과가 있는 항균, 항산화 및 항염억제제 및 이를 함유하는 화장료 조성물 | |
KR100924920B1 (ko) | 바위손 추출물을 함유하는 여드름 예방 또는 치료용 조성물 | |
CN105662962B (zh) | 一种基于高纯度草本提取物的祛痘膏及其制备方法 | |
JP6054700B2 (ja) | 脱糖化剤及び皮膚外用剤 | |
Dai et al. | Honey in traditional Chinese medicine: A guide to future applications of NADES to medicines | |
CN103755829A (zh) | 一种壶瓶枣多糖的制备方法 | |
KR100899278B1 (ko) | 화장료 조성물 | |
Kamel et al. | Phytochemical screening, acute toxicity, analgesic and anti-inflammatory effects of apricot seeds ethanolic extracts | |
CN101837071B (zh) | 植物提取物的组合物及预防治疗疤痕的应用 | |
CN108210435A (zh) | 一种杀菌消痘绿色祛斑防晒护肤霜及其制备方法 | |
CN102618425B (zh) | 元宝枫保健酒及其制备方法 | |
KR102166300B1 (ko) | 다기능성 미용비누 조성물 및 그 조성물을 이용한 다기능성 미용비누의 제조방법 | |
CN109453327B (zh) | 一种具有祛痘功效的中药组合物及其水提物和发酵物以及应用 | |
CN113520954A (zh) | 一种中药祛痘膏及其生产工艺 | |
KR20080090186A (ko) | 모발생장촉진용 조성물 | |
EP2897906B1 (en) | Process for bio synthesis of nano arsenic trioxide and its use in treatment of diseases including cancers | |
KR101211754B1 (ko) | 천연 추출물을 함유하는 스트레스성 여드름 개선용 화장료 조성물 | |
CN101869543A (zh) | 一种含有菠萝、木瓜酶、柚子、艾叶素、珍珠的生物康洗露 | |
CN111904911B (zh) | 一种含三七的植物抗氧化组合物及其应用 | |
CN111419940B (zh) | 一种祛痘的中草药组合物 | |
CN110812377B (zh) | 一种痤疮治疗修复组合物及其应用 | |
KR20230078901A (ko) | 커먼자스민, 흰버드나무껍질 및 가지열매 추출물을 포함하는 피지 조절 및 모공 개선용 조성물 | |
CN114306410A (zh) | 一种紫草膏及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211022 |
|
RJ01 | Rejection of invention patent application after publication |